Status
Conditions
About
Direct acting antivirals offer a new opportunity to monitor the immune response in Hepatitis C infection. In this study cytokine markers will be measured during therapy up to time point SVR 12 an correlated to clinical Parameters and regular laboratory findings.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Georg Peschel; Kilian Weigand
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal